Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

Cited In for PubMed (Select 11331054)

1.

Comparison of spironolactone and trichlormethiazide as add-on therapy to renin-angiotensin blockade for reduction of albuminuria in diabetic patients.

Hase M, Babazono T, Ujihara N, Uchigata Y.

J Diabetes Investig. 2013 May 6;4(3):316-9. doi: 10.1111/jdi.12029. Epub 2013 Jan 24.

2.

Long-term effects of spironolactone in peritoneal dialysis patients.

Ito Y, Mizuno M, Suzuki Y, Tamai H, Hiramatsu T, Ohashi H, Ito I, Kasuga H, Horie M, Maruyama S, Yuzawa Y, Matsubara T, Matsuo S; Nagoya Spiro Study Group.

J Am Soc Nephrol. 2014 May;25(5):1094-102. doi: 10.1681/ASN.2013030273. Epub 2013 Dec 12.

PMID:
24335969
3.

Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis.

Hu LJ, Chen YQ, Deng SB, Du JL, She Q.

Br J Clin Pharmacol. 2013 May;75(5):1202-12. doi: 10.1111/bcp.12012. Review.

4.

The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease.

Edwards NC, Steeds RP, Chue CD, Stewart PM, Ferro CJ, Townend JN.

Br J Clin Pharmacol. 2012 Mar;73(3):447-54. doi: 10.1111/j.1365-2125.2011.04102.x.

5.

Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.

Weir MA, Juurlink DN, Gomes T, Mamdani M, Hackam DG, Jain AK, Garg AX.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1544-51. doi: 10.2215/CJN.01970310. Epub 2010 Jul 1.

6.

Diabetes and drug-associated hyperkalemia: effect of potassium monitoring.

Raebel MA, Ross C, Xu S, Roblin DW, Cheetham C, Blanchette CM, Saylor G, Smith DH.

J Gen Intern Med. 2010 Apr;25(4):326-33. doi: 10.1007/s11606-009-1228-x. Epub 2010 Jan 20.

7.

The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study.

Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J.

Scand J Prim Health Care. 2009;27(3):153-9. doi: 10.1080/02813430902992215.

8.

Tolerability of spironolactone in patients with chronic heart failure -- a cautionary message.

Witham MD, Gillespie ND, Struthers AD.

Br J Clin Pharmacol. 2004 Nov;58(5):554-7.

10.

Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.

Wrenger E, Müller R, Moesenthin M, Welte T, Frölich JC, Neumann KH.

BMJ. 2003 Jul 19;327(7407):147-9. No abstract available.

11.

Nephrotoxicity in the elderly due to co-prescription of ACE inhibitors and NSAIDs.

Jolobe OM.

J R Soc Med. 2001 Dec;94(12):657-8. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk